Barry E. Gidal

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

Lesley Taylor, Barry E. Gidal, Graham Blakey et al. · CNS Drugs · 2018 · 448 citations · Full text

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy

Andrés M. Kanner, Eric Ashman, David Gloss et al. · Neurology · 2018 · 200 citations · Full text

Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression.

Pamela S. Wiegartz, Michael Seidenberg, Austin Woodard et al. · PubMed · 1999 · 184 citations

Neuropsychiatry, Mental Health, Epilepsy +18

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability

Barry E. Gidal, Louis L. Radulovic, Sarah Kruger et al. · Epilepsy Research · 2000 · 145 citations

Pharmacokinetic Modeling, Biochemistry, Pharmacological Study +6

Refractory status epilepticus

Raj D. Sheth, Barry E. Gidal · Neurology · 1998 · 138 citations

Neurological Disorder, Psychotropic Medication, Pharmacotherapy +19